• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.10% Nasdaq Down 1.82%

    Immunomedics Inc. (IMMU)

    -NasdaqGM
    1.97 Down 0.23(10.45%) 4:00PM EST
    Prev Close:2.20
    Open:2.18
    Bid:1.96 x 20600
    Ask:1.97 x 6900
    1y Target Est:2.00
    Beta:1.34517
    Earnings Date:May 4 - May 9 (Est.)
    Day's Range:1.95 - 2.18
    52wk Range:1.50 - 5.05
    Volume:1,715,599
    Avg Vol (3m):757,254
    Market Cap:186.64M
    P/E (ttm):N/A
    EPS (ttm):-0.57
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMMU

    Comparison

    Symbol% ChgMkt Cap
    IMMUDown 10.45%186.64M
    GSKDown 3.16%95.52B
    BIIBDown 4.96%54.84B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):41.85
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-16) :-0.31
    Quarterly EPS Est (Mar-16) :-0.13
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Immunomedics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback